• CIMG reported revenue of $3.21 million for the three months ended March 31, 2026, swinging from no revenue a year earlier.
• Net loss widened to $15.43 million from $385,556, driven by higher labor and professional expenses, plus fair value measurement of digital assets.
• Operating expenses climbed 77.74% to $1.34 million.
• Gross profit was $13,653, with gross margin of 0.42%.
• Computing Power Product Series led quarterly revenue with $2.65 million, followed by Homology of Medicine and Food at $428,786 and Maca products at $136,420.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CIMG Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-022159), on May 11, 2026, and is solely responsible for the information contained therein.